Our goal is to ensure the next generation grows up safe from deadly infectious diseases. We work with partners to develop safe and effective vaccines that protect against preventable diseases and to expand access to these vaccines for people in lower-income countries.
Dr. Erin Stuckey of the foundation’s polio eradication team shares details on the team’s pivot to COVID-19. They underscore the importance of using the response to strengthen health systems—because when…
Bill & Melinda Gates Foundation CEO Mark Suzman shares measures the public can take to help curb COVID-19 from home. By collectively following public health guidance, practicing physical distancing, and…
Allan Golston, president of U.S. Programs at the Bill & Melinda Gates Foundation, delves into the foundation’s strategy for education during and after COVID-19 to ensure successful and equitable online…
Amy Carter, director of Community Engagement, discusses the two-pronged approach the foundation is taking to tackle COVID-19 in Seattle: deploying money and expertise.
Monalisa Chatterji, a senior program officer for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team, works on the discovery of novel candidate therapeutics.
Interview with Trevor Mundel on COVID-19. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The…
Interview with Ken Duncan on COVID-19 (novel coronavirus). Duncan leads drug discovery efforts for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team.
Interview with Valerie Nkamgang Bemo on COVID-19. Bemo manages the Bill & Melinda Gates Foundation’s investments that support communities affected by natural disasters and complex emergencies.
